About
About IVD Medical Holding Limited
ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analysers and reagents. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. The company was formerly known as IVD Medical Holding Limited and change its name to ETHK Labs Inc. in December 2025. ETHK Labs Inc. was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.
Visit company website
5 years, 5 months ago
IVD Medical Holding Limited is currently in a long term uptrend where the price is trading 35.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
IVD Medical Holding Limited's total revenue rose by 1.9% to $1B since the same quarter in the previous year.
Its net income has increased by 253.4% to $120M since the same quarter in the previous year.
Finally, its free cash flow fell by 188.5% to $-116M since the same quarter in the previous year.
Based on the above factors, IVD Medical Holding Limited gets an overall score of 4/5.